嘉实医药健康股票A(005303)利润分配表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
收入 |
157,701,913.59 |
-147,788,378.77 |
-183,342,277.82 |
-202,192,602.85 |
利息合计 |
71,289.93 |
149,567.01 |
58,708.31 |
103,592.11 |
其中:存款利息收入 |
71,289.93 |
149,567.01 |
58,708.31 |
103,592.11 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-20,446,514.56 |
-205,382,070.76 |
-173,094,983.22 |
-261,494,061.81 |
其中:股票投资收益 |
-24,839,156.65 |
-224,998,079.68 |
-184,157,137.44 |
-274,863,590.51 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
233,011.02 |
2,618,303.64 |
773,338.76 |
1,357,601.02 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
4,159,631.07 |
16,997,705.28 |
10,288,815.46 |
12,011,927.68 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
178,005,251.01 |
57,233,684.96 |
-10,418,069.67 |
58,320,335.37 |
其他收入 |
71,887.21 |
210,440.02 |
112,066.76 |
877,531.48 |
费用 |
7,753,391.33 |
17,982,677.47 |
9,518,046.55 |
28,108,019.57 |
管理人报酬 |
5,870,204.90 |
13,503,457.07 |
7,094,025.81 |
21,274,451.17 |
基金托管费 |
978,367.46 |
2,250,576.16 |
1,182,337.63 |
3,545,741.79 |
销售服务费 |
794,304.05 |
2,010,098.92 |
1,111,305.10 |
3,017,125.38 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
110,514.92 |
218,542.32 |
130,378.01 |
270,701.23 |
利润总额 |
149,948,522.26 |
-165,771,056.24 |
-192,860,324.37 |
-230,300,622.42 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年